Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
1.820
+0.020 (1.11%)
At close: Dec 24, 2025, 1:00 PM EST
1.810
-0.010 (-0.55%)
After-hours: Dec 24, 2025, 4:55 PM EST
Nkarta Market Cap
Nkarta has a market cap or net worth of $128.56 million as of December 24, 2025. Its market cap has decreased by -26.24% in one year.
Market Cap
128.56M
Enterprise Value
-77.13M
1-Year Change
-26.24%
Ranking
Category
Stock Price
$1.82
Market Cap Chart
Since July 10, 2020, Nkarta's market cap has decreased from $1.46B to $128.56M, a decrease of -91.22%. That is a compound annual growth rate of -35.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 128.56M | -26.83% |
| Dec 31, 2024 | 175.72M | -45.75% |
| Dec 29, 2023 | 323.88M | 10.77% |
| Dec 30, 2022 | 292.39M | -42.19% |
| Dec 31, 2021 | 505.77M | -74.76% |
| Dec 31, 2020 | 2.00B | 36.85% |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.53B |
| Johnson & Johnson | 495.78B |
| AbbVie | 404.36B |
| UnitedHealth Group | 294.22B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 260.71B |
| Novo Nordisk | 232.28B |